In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Jason Moser about the latest headlines and earnings reports from Wall Street. They share some vaccine news and talk about how it's impacting a steadily growing global consulting company. They discuss whether Snap (NYSE: SNAP) will win where others have failed with its new feature. They answer a listener question, talk about the value of ETFs in investing, and much more.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
Source Fool.com